News
October 2008
BMS 115 named Facility of the Year
Bristol-Myers Squibb’s Building 115 Clinical Supplies Operations (CSO) and Drug Product Technology Center (PTC) Expansion in New Brunswick, New Jersey, was selected as category winner of the 2008 Facility of the Year Awards (FOYA.)
The annual awards program recognizes state-of-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high-quality medicines. Sponsored by ISPE, INTERPHEX and Pharmaceutical Processing, the Awards effectively spotlight the accomplishments, shared commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of all global consumers.
The Equipment Innovation category for which the BMS B115 project was honored, recognizes novel application of commercially available and custom developed process manufacturing and facility management tools, which yield superior results, advanced manufacturing technologies and improved competitive position.
Phase one implemented a state-of-the-art Clinical Supply Operations expansion facility-including full containment for expanded Oral Solid Dose (OSD) operations and the most flexible clinical-scale continuous barrier line in the United States for Sterile products. This highly technical facility was designed for manufacturing OSD batches up to 400Kg and parenteral liquid fill batches up to 250L. The goal was to create a flexible facility capable of performing multi-product clinical scale manufacturing and processing solvent-based and potent compound operations. The first phase consisted of approximately 93,110 sq. ft. including processing, manufacturing, support, and mechanical space.
Phase Two built upon the technologies in Phase One and added additional processing space and scale to the Oral Solid Dose clinical operation and a new stand-alone Product Technology Center for development scale-up activities. The addition to Oral Solid Dose Operations allows the manufacture of Long Term Stability batches within the Clinical Supply Operations facility in at least one-tenth commercial scale.
Torcon was construction manager for both phases of the BMS project, working closely with designer IPS and the BMS team. A phased approach was initiated to adapt an existing building to allow full implementation of lessons learned as containment and process automation technology was integrated into existing operation.